News

Mr Rueckert is the managing member of Oyster Management Group, and is a director of Glycotex, an 83% owned unlisted subsidiary of Novogen. He was formerly a director

More specifically, VGX will design and test DNA vaccine candidates using target antigens from Plasmodium species and deliver them intradermally using the Cellectra constant current electroporation device. The

According to the company, the Jetstream G2 is a peripheral atherectomy catheter designed to remove all kinds of artery-clogging plaque in the lower limbs of patients. This minimally

Endo has acquired Indevus through a tender offer and subsequent merger upon which Indevus became a wholly owned subsidiary of Endo. The common stock of Indevus ceased trading

The complaint, which was filed in the US District Court of Delaware, alleges infringement of US patents, which expire on September 24, 2019, and another US patent which

The trial has three arms comparing single agent adecatumumab to combination chemotherapy (Folfox: 5-FU/Leucovorin plus Oxaliplatin), and to Folfox followed by adecatumumab. The primary endpoint will be the

Medicis, a specialty pharmaceutical company, and Teva Pharmaceutical Industries, a generic pharmaceutical company, have agreed to terminate all legal disputes between them relating to Solodyn extended release tablets.

Plexxikon, a developer of small molecule pharmaceuticals, has received key composition-of-matter patents covering novel compounds discovered through the company’s Scaffold-based Drug Discovery platform. Two of the three recently

Mr Parkinson will replace David Swetlow, vice president of finance and operations, who is leaving Protox to pursue entrepreneurial opportunities. Previously, Mr Parkinson was vice president of finance